Addex Therapeutics (ADXN) Enterprise Value: 2022-2025
Historic Enterprise Value for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $4.9 million.
- Addex Therapeutics' Enterprise Value fell 28.97% to $4.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.9 million, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $1.9 million for FY2024, which is 465.42% up from last year.
- As of Q2 2025, Addex Therapeutics' Enterprise Value stood at $4.9 million, which was up 71.94% from $2.9 million recorded in Q1 2025.
- Addex Therapeutics' Enterprise Value's 5-year high stood at $2,320.2 billion during Q3 2023, with a 5-year trough of -$7,958.2 billion in Q2 2023.
- In the last 3 years, Addex Therapeutics' Enterprise Value had a median value of $3.7 million in 2023 and averaged -$563.8 billion.
- Over the last 5 years, Addex Therapeutics' Enterprise Value had its largest YoY gain of 14,985,219.58% in 2023, and its largest YoY loss of 420,549,626.74% in 2023.
- Addex Therapeutics' Enterprise Value (Quarterly) stood at -$3.2 million in 2022, then surged by 82.08% to -$581,837 in 2023, then surged by 428.87% to $1.9 million in 2024, then decreased by 28.97% to $4.9 million in 2025.
- Its Enterprise Value was $4.9 million in Q2 2025, compared to $2.9 million in Q1 2025 and $1.9 million in Q4 2024.